Discriminatory proteomic biomarker analysis identifies free hemoglobin in the cerebrospinal fluid of women with severe preeclampsia
- 1 September 2005
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 193 (3) , 957-964
- https://doi.org/10.1016/j.ajog.2005.06.055
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Proteomic biomarkers that predict the clinical success of rescue cerclageAmerican Journal of Obstetrics and Gynecology, 2005
- Proteomic biomarker analysis of amniotic fluid for identification of intra‐amniotic inflammationBJOG: An International Journal of Obstetrics and Gynaecology, 2005
- Recommendations for CSF analysis in subarachnoid haemorrhageJournal of Neurology, Neurosurgery & Psychiatry, 2004
- A novel and accurate diagnostic test for human African trypanosomiasisThe Lancet, 2004
- Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's diseaseMolecular Brain Research, 2003
- Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteinsMolecular Brain Research, 2002
- ACP Best Practice No 166: CSF spectrophotometry in the diagnosis of subarachnoid haemorrhageJournal of Clinical Pathology, 2001
- Blood-pressure measurement and classification in pregnancyThe Lancet, 2001
- What is the Role of CSF Spectrophotometry in the Diagnosis of Subarachnoid Haemorrhage?Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1998
- Eclampsia in the United KingdomBMJ, 1994